Register for Zoom In On Dementia & Alzheimer’s
Register for Zoom In On Dementia & Alzheimer’s
TITLE
Coming Soon!
DATE
Thursday, February 11, 2027
TIME
1 pm ET (please adjust for your time zone)
SPEAKER(S)
Suzanne Hendrix, CEO, Pentara Corporation
Watch Past Episodes
From Schizophrenia to Alzheimer’s: Understanding the KarXT Clinical Trials
Could a breakthrough drug originally approved for schizophrenia help address some of the most challenging symptoms of Alzheimer’s disease? Dr. Paul Newhouse explains the emerging science behind KarXT (now FDA-approved for schizophrenia as Cobenfy).
What’s New in Alzheimer’s Blood Testing
In this timely discussion, Dr. Suzanne Schindler will explain how blood-based biomarkers are transforming Alzheimer’s diagnosis, research, and care.
Trontinemab: A New Brain-Penetrant Alzheimer’s Therapy
Dr. Gil Rabinovici explores trontinemab, an investigational next-generation anti-amyloid therapy being studied for early Alzheimer’s disease.
Reducing Dementia Risk: What New Research Reveals
Dr. Zaldy Tan discusses what the newest research reveals about protecting brain health and promoting healthy aging.
Lewy Body, Alzheimer’s & Mixed Dementias Explained
Leading neurologist Dr. James E. Galvin explains how to identify early warning signs, distinguish Lewy body dementia from Alzheimer’s disease, and explore current and emerging treatment options.
Agitation in Alzheimer’s Dementia
Dr. Brent Forester explains what causes agitation, how it may appear in different forms, and the latest approaches for managing symptoms—including non-drug strategies and newly approved treatments.
Stroke, Vascular Dementia, Alzheimer’s: What’s the Difference?
Dr. Jason Hinman of UCLA explains how disrupted blood flow to the brain can lead to cognitive decline, how vascular dementia differs from (and often overlaps with) Alzheimer’s disease, and what the latest research means for prevention and treatment.
Therapeutic TV for Alzheimer’s: What the Research Shows
Allyson Schrier shares how research following her experience caring for her husband with dementia led her to create a streaming service designed to calm, engage, and support people living with memory loss.
The SPRING Trial: Targeting Gum Bacteria in Alzheimer’s
Dr. Michael J. Detke of Lighthouse Pharma explains the SPRING clinical trial and how the investigational oral drug LHP588 is being studied to reduce bacteria-related brain damage.
Zoom In on Dementia & Alzheimer’s is supported in part through sponsorships from:
